Table 2.
Demographic data and comparative studies between the control and sepsis patient groups regarding MPO, CIT-HIST-H3 levels, and other laboratory investigations.
| Parameters | Control group | Sepsis patient group | P-value | |
|---|---|---|---|---|
| No. = 80 | No. = 138 | |||
| Age | Mean ± SD | 54.8 ± 18.34 | 53.93 ± 18.45 | 0.736 |
| Range | 16–89 | 16–89 | ||
| Sex | Male | 32 (40.0%) | 50 (36.2%) | 0.759* |
| Female | 48 (60.0%) | 88 (63.8%) | ||
| HB g/dL | Mean ± SD | 13.12 ± 1.23 | 9.81 ± 1.81 | 0.000• |
| Range | 11.1–15.8 | 5.1–17 | ||
| WBCs (x103/ul) | Mean ± SD | 7.74 ± 1.58 | 13.14 ± 4.94 | 0.000• |
| Range | 4.4–10.5 | 3.4–32.8 | ||
| N/L ratio | Median (IQR) | 2.19(1.19–3.09) | 8.7(6.19–14.47) | 0.000≠ |
| Range | 0.68–8.9 | 0.77–115 | ||
| PLTs (x103/ul) | Median (IQR) | 264(230–309) | 124(66–184) | 0.000≠ |
| Range | 181–344 | 2–602 | ||
| PT (sec) | Mean ± SD | 13.64 ± 1.66 | 20.16 ± 9.56 | 0.017• |
| Range | 10.6–16.6 | 12.9–70.5 | ||
| INR | Mean ± SD | 1.03 ± 0.11 | 1.84 ± 0.93 | 0.003• |
| Range | 0.87–1.25 | 1.13–5.84 | ||
| PTT (sec) | Mean ± SD | 33.74 ± 6.46 | 53.3 ± 29.18 | 0.050• |
| Range | 20.2–40.7 | 23.9–140 | ||
| CRP (< 5 mg/L) | Median (IQR) | 5 (3.5–9) | 103 (43.5–203) | 0.000≠ |
| Range | 0.3–22.1 | 15–396 | ||
| FDPs (< 5 Ug/ml) | Median (IQR) | – | 24.3 (12–40) | – |
| Range | – | 3–170 | ||
| D dimer (0-0.55 Ug/ml) | Median (IQR) | – | 2.29 (1.7–5) | – |
| Range | – | 0.98–7 | ||
| Fibrinogen (2–4 g/L) | Median (IQR) | – | 3.3 (2–5.1) | – |
| Range | – | 0.5–9 | ||
| PCT (up to 0.05 ng/ml) | Median (IQR) | – | 12.3 (2–45) | – |
| Range | – | 0.05–110 | ||
| Total Bilirubin mg/dl | Median (IQR) | – | 1.3 (1.25–2.1) | – |
| Range | – | 0.5–8 | ||
| Creatinine mg/dl | Median (IQR) | – | 1.5 (1.01–2.01) | – |
| Range | – | 0.8–5.5 | ||
| MPO (ng/ml) | Median (IQR) | 2.01 (0.9–2.8) | 73.7 (62.1–84.1) | 0.000≠ |
| Range | 0.21–3.69 | 36.4–124.8 | ||
| CIT-HIST-H3 (ng/ml) | Median (IQR) | 1.38 (0.81–2.19) | 106.3 (66.4–193.3) | 0.000≠ |
| Range | 0.49–3.62 | 18.2–376.9 | ||
| SOFA score | Median (IQR) |
– – |
5 (5–8) | – |
| Range | 3–17 | |||
| Overall Mortality rate among the Studied sepsis group | – | 49/138 (35.5%) | – | |
| Mortality rate among the Studied sepsis group in the initial 7 days | – | 24/138 (17.4%) | – | |
| Catecholamine infusion rate in the sepsis group | – | 104/138 (75.4%) | – | |
| Use of mechanical ventilation rate in the sepsis group | – | 80/138 (57.9%) | – | |
| Extrarenal replacement therapy (RRT) in the sepsis group | – | 5/138 (3.6%) | – | |
P-value > 0.05: Non-significant; P-value < 0.05: Significant; P-value < 0.01: Highly significant •: Independent t-test; ≠: Mann-Whitney test, *: Chi-square test.